Status:
COMPLETED
PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
Asia Diabetes Foundation
Conditions:
Diabetes
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Quality diabetes care requires informed-decisions of motivated care providers and diabetes patients. The investigators aim to use peer support and information technology to facilitate care providers t...
Detailed Description
In this global epidemic of diabetes and obesity, more than 60% of affected people will come from Asia with the most rapid increase in the young to middle aged group. This rapid increase in young onset...
Eligibility Criteria
Inclusion
- 1\) Type 2 diabetic patients with medium or moderate risk for complications (stratified by JADE Program, Care Levels 2 to 4) and followed up 3-4 monthly according to the JADE Program. Based on our 6000-patient registry, these risk levels clearly separate diabetes patients based on risk of future clinical events.
- 2\) Men/women aged 18-70 years (inclusive), functionally independent and with informed written consent.
Exclusion
- 1\) Patients with one or no risk factors (low risk, Care Level 1 by JADE Program) as stratified by the JADE Risk Engine.
- 2\) Patients with reduced life expectancy and unstable mood or major psychiatric conditions.
- 3\) Patients who cannot communicate in Chinese language.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
632 Patients enrolled
Trial Details
Trial ID
NCT00950716
Start Date
September 1 2009
End Date
February 1 2015
Last Update
August 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asia Diabetes Foundation
Hong Kong, China